Cannabis Law Report

NOVEMBER 2, 2021

NORML is pleased to announce that its newly updated and revised publication, Clinical Applications for Cannabis & Cannabinoids: A Review of the Recent Scientific Literature, 2000 — 2021 , is now available for download on the Kindle app. Proceeds from the purchase of the new book directly fund NORML’s cannabis advocacy efforts.

Safety 52

Safety Patients Chronic Pain Advocacy 52

The Cannigma

FEBRUARY 11, 2021

One of the things she does is collect and analyze data about cannabis products and how patients with different medical conditions respond to them. All of that data is packaged into software doctors can use to manage their patients’ medical marijuana treatment. “I I know how to collect data. I know how to analyze data.

Wellness and Beauty 125

Wellness and Beauty Data Patients Medicine 125

Veriheal

OCTOBER 29, 2020

billion was funded into cannabis research between 2000 and 2018. The data for this graphic was provided by Jim Hudson at Hellth.com. . The data provided by Mr. Hudson allows citizens to see how the main share of funding is allocated to seek the negative consequences of cannabis. The cannabis research database displayed that $1.56

Pharmaceutical 98

Pharmaceutical Therapy Cannabinoids Chronic Pain 98

Sensi Seeds

DECEMBER 10, 2018

They evaluate data, which is now available thanks to the efforts of the cannabis policy reform movement, and try to provide answers, especially to those who need them most, namely, medical patients. Consequently, they sorted the publications into three main groups: psychiatry, cancer treatment, and neurology. ” An Encouraging Increase.

Medicine 81

Medicine Research and Development Data Policy 81

Veriheal

OCTOBER 5, 2020

The qualifying conditions for medical cannabis has been established in the bill as follows: Amyotrophic Lateral Sclerosis (ALS), Cachexia, Cancer, Chronic Pain, Crohn’s Disease, Epilepsy, Glaucoma, HIV/Aids, Lupus, Multiple Sclerosis, Nausea, Persistent Muscle Spasms, Post-traumatic Stress Disorder (PTSD), Rheumatoid Arthritis. .

Edibles 52

Edibles Legalization Decriminalization Consumption 52

Cannabis Law Report

NOVEMBER 24, 2021

Using a content analysis approach, we investigated articles about medicinal cannabis from 2000 to the end of 2019 in the Medical Journal of Australia, Australian Doctor , Medical Observer , Australian Journal of General Practice , Australian Family Physicia n , and Australian Medicine. Data collection.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

SEPTEMBER 19, 2019

CBD does not create the same high as THC and can be used for chronic pain and anxiety relief, according to Harvard Medical School. Both hemp and marijuana can be used to create CBD extracts, but hemp has a higher concentration of the compound. Both hemp and marijuana have extreme physical similarities. ” In October 2018, the U.S.

Vaping 55

Vaping Hemp Education Patients 55